| Sources | Names Used |
|---|---|
| GDSC1000 | Zibotentan |
| PharmacoGx | Zibotentan |
| Database | Identifier |
|---|---|
| Smiles: | COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(cc1)-c1nnco1 |
| Pubchem: | 9910224 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KRAS | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | THEG | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | AGL | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | CDC14A | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | UPK2 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | SEPHS2 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | TRIM41 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | RHO | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | EYA1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | TNP2 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
